TOPLINE
·
SUBSCRIBERS

Q&M eyes AI and tech investments for future growth

Firm's new AI platform meant to reduce the chance of misdiagnoses, recommend treatment plans in a more objective, transparent way.

Claudia Chong
Published Mon, Jun 21, 2021 · 05:50 AM

Singapore

A FLAW in the dental industry lies in how some dentists prescribe treatment plans simply because they prefer certain procedures. This comes at the expense of patients, said Ng Chin Siau, chief executive of Q&M Dental Group.

In 2018, Q&M established a company, EM2AI, to work on artificial intelligence (AI) projects that target pain points such as this. EM2AI is now preparing for clinical trials to get approval from the Health Sciences Authority for its AI platform, under the Class B medical device category.

KEYWORDS IN THIS ARTICLE

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to  t.me/BizTimes

Companies & Markets

SUPPORT SOUTH-EAST ASIA'S LEADING FINANCIAL DAILY

Get the latest coverage and full access to all BT premium content.

SUBSCRIBE NOW

Browse corporate subscription here